ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications.
作者信息
Dominguez Dana A, Melstrom Laleh G
机构信息
Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA, USA.
出版信息
Ann Surg Oncol. 2024 Aug;31(8):4942-4943. doi: 10.1245/s10434-024-15172-5. Epub 2024 Mar 12.
Abstract
摘要
相似文献
1
ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications.ASO作者反思：切除的胆管癌辅助放化疗——见解与启示
Ann Surg Oncol. 2024 Aug;31(8):4942-4943. doi: 10.1245/s10434-024-15172-5. Epub 2024 Mar 12.
2
ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers.ASO作者反思：辅助放化疗用于切除的胆管癌患者
Ann Surg Oncol. 2020 Dec;27(13):5173-5174. doi: 10.1245/s10434-020-08970-0. Epub 2020 Aug 3.
3
Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809.
Ann Surg Oncol. 2024 Aug;31(8):4837-4838. doi: 10.1245/s10434-024-15323-8. Epub 2024 May 2.
4
ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers-Does One Size Fit All?ASO作者反思：切除的胆管癌辅助化疗——一刀切可行吗？
Ann Surg Oncol. 2023 Aug;30(8):4822-4823. doi: 10.1245/s10434-023-13584-3. Epub 2023 May 6.
5
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.比较辅助同步放化疗与化疗对可切除胆道癌的疗效。
BMC Gastroenterol. 2020 Jan 28;20(1):20. doi: 10.1186/s12876-020-1171-1.
6
Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?接受手术切除的胆管癌患者中，哪些亚组从辅助放化疗中获益最大？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):934-936. doi: 10.1245/s10434-020-09128-8. Epub 2020 Sep 11.
7
Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.可切除胆管癌的辅助和新辅助治疗的作用。
Expert Rev Gastroenterol Hepatol. 2021 May;15(5):537-545. doi: 10.1080/17474124.2021.1911645. Epub 2021 Apr 13.
8
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma.一项关于吉西他滨联合多西他赛辅助治疗后同步放化疗用于可切除胰胆管癌的II期研究。
HPB (Oxford). 2015 Jul;17(7):587-93. doi: 10.1111/hpb.12413. Epub 2015 Mar 20.
9
Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO).手术治疗的胆道癌的预后因素及辅助治疗：安纳托利亚医学肿瘤学会（ASMO）的多中心研究
Asian Pac J Cancer Prev. 2014;15(22):9687-92. doi: 10.7314/apjcp.2014.15.22.9687.
10
Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor.辅助治疗中接受手术切除的胆管癌患者的放化疗：对一封致编辑信的回复
Ann Surg Oncol. 2020 Dec;27(Suppl 3):937-939. doi: 10.1245/s10434-020-09130-0. Epub 2020 Sep 10.
引用本文的文献
1
Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809.
Ann Surg Oncol. 2024 Aug;31(8):4837-4838. doi: 10.1245/s10434-024-15323-8. Epub 2024 May 2.
本文引用的文献
1
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.SWOG S0809：一项关于肝外胆管癌和胆囊癌辅助性卡培他滨和吉西他滨治疗后放疗及同步卡培他滨的II期组间试验。
J Clin Oncol. 2015 Aug 20;33(24):2617-22. doi: 10.1200/JCO.2014.60.2219. Epub 2015 May 11.
Zotero 插件